Transaction · 0001193125-26-429073

Paul Steven M

PAUL STEVEN M, DIR, reported an open-market or private purchase at Rapport Therapeutics, Inc. involving 35714.000000 shares for an estimated $974277.92. Reported holdings after the transaction were 77380.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR
RAPPRapport Therapeutics, Inc.
Trade date
Oct 22, 2026
Filing date
Oct 22, 2026
View on SEC Insider profile
Estimated value$974kShares × reported price
Shares traded35.7k$27.28 per share
Holdings after77.3kIndirect · By Paul Capital Strategy III Fund LLC
% of reported position traded85.71%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 41,666 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

RAPP price since this filing

Daily closing prices, with the filing date and available return windows
RAPP · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +65.5%1w ago +18.0%1d ago +0.0%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001193125-26-429073
Common Stock
Transaction date
Oct 22, 2026
Filed Oct 22, 2026, 08:56 PM · 0d delay
Shares
35,714 sh
$27.28 per share
Estimated value
$974k
Computed from shares × price
Holdings after
77,380 sh
Indirect · By Paul Capital Strategy III Fund LLC

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Buy Director Buy Large Holdings Increase
Filing-only score

+44 points

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • director_buy+6 points

    is_director = true

    Director open-market purchase.
  • cluster_buy+14 points

    cluster-buy signal matched

    Multiple insiders bought within the configured window.
  • large_holdings_increase+8 points

    large-holdings-increase signal matched

    Reported acquired shares meet the configured percentage of post-transaction holdings.
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $26.87 to $27.84, inclusive. The Reporting Person undertakes to pr…

  2. F2

    Shares held by Paul Capital Strategy III Fund LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.

Original filing · 0001193125-26-429073
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

RAPP